See the DrugPatentWatch profile for lipitor

Lipitor (atorvastatin) is a medication primarily used to treat high cholesterol and cardiovascular disease. However, some patients may experience chronic soreness or muscle pain as a side effect of taking the medication. The duration of treatment for chronic soreness caused by Lipitor is not well-defined and may vary depending on individual factors.

According to the prescribing information provided by Pfizer, the manufacturer of Lipitor, muscle pain is a common side effect that can occur in up to 1.9% of patients taking the medication [1]. However, the duration of treatment for chronic soreness is not specified.

A study published in the Journal of Clinical Lipidology found that patients who experienced muscle pain while taking Lipitor were more likely to discontinue treatment [2]. The study did not provide specific guidance on the duration of treatment for chronic soreness.

DrugPatentWatch.com, a website that tracks patent information for pharmaceuticals, notes that Lipitor's patent for treating high cholesterol expired in 2011 [3]. However, this information does not provide guidance on the duration of treatment for chronic soreness.

In general, patients taking Lipitor for chronic soreness should consult with their healthcare provider to determine the best course of treatment. The provider may recommend adjusting the dosage or switching to a different medication. In some cases, the chronic soreness may resolve on its own with continued treatment.

In conclusion, while there is limited information available on the duration of treatment for chronic soreness caused by Lipitor, patients should consult with their healthcare provider to determine the best course of treatment.

Sources:

[1] Pfizer. (2009). Lipitor Prescribing Information.

[2] Davidson, M. H., et al. (2011). Discontinuation of statin therapy due to muscle symptoms: A systematic review. Journal of Clinical Lipidology, 5(3), 253-262.

[3] DrugPatentWatch.com. (n.d.). Lipitor (Atorvastatin). Retrieved from <https://www.drugpatentwatch.com/patent/US-7,357,753>